Brief: CytoDyn To File Accelerated Rolling Review With MHRA And Interim Order With Health Canada For COVID-19
08/03/2021 11:41
March 8 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN TO FILE ACCELERATED ROLLING REVIEW WITH MHRA AND
INTERIM
ORDER (IO) WITH HEALTH CANADA FOR COVID-19
Source text for Eikon: ID:nGNX8MJMy0
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer